Department of Gynecologic Oncology, Cancer Hospital of Fudan University, 399 Ling-Ling Road, Shanghai, China.
Gynecol Oncol. 2011 Jun 1;121(3):565-70. doi: 10.1016/j.ygyno.2011.01.032. Epub 2011 Feb 21.
To report our experience of radical abdominal trachelectomy for patients with cervical malignancies.
We conducted a retrospective review of a prospectively maintained database of patients undergoing fertility-sparing radical abdominal trachelectomy for cervical malignancies at our institution from 04/2004 to 09/2010.
Sixty-four patients with cervical malignancies underwent laparotomy for planned radical abdominal trachelectomy. Two patients needed immediate completion of radical hysterectomy due to unfavorable intraoperative findings. Median age was 29.5 years (range, 11-41). Histology included 8 (12.9%) with adenocarcinoma, 50 (80.65%) with squamous carcinoma, 1 (1.61%) with adenosquamous carcinoma and 3 (4.84%) with botryoid sarcoma. Median number of nodes evaluated was 25 (range, 12-53); Ten (16.13%) patients with pathologic risk factors received adjuvant therapy. Fourteen of 36 IB1 cases had tumor size >2cm. No recurrences were observed at a median follow-up of 22.8 months. Five (8.06%) patients developed postoperative cervical stenosis--all occurred before we started to routinely install T-IUDs during the procedure. Thirty-eight patients completed the survey which aimed to understand what factors influenced these patients' reproductive outcomes. For various reasons, only 10 patients attempted to conceive and 2 of them succeeded. One of them delivered by cesarean section after 39 weeks and the other is currently pregnant.
Radical abdominal trachelectomy seems to be a reasonable option for selected patients whose tumors are no larger than 4cm when conducted by experienced gynecologic oncologists. The main perioperative complication is postoperative cervical stenosis, which could be effectively prevented by installation of a tailed T-IUD during the surgery. Social, familial and physical factors can largely influence the patients' reproductive outcomes. The issues of reproductive concerns and quality of life require further investigation.
报告我们在机构中进行保留生育功能的根治性腹部子宫颈切除术治疗宫颈癌患者的经验。
我们对 2004 年 4 月至 2010 年 9 月期间因宫颈癌接受保留生育功能的根治性腹部子宫颈切除术的患者前瞻性维护的数据库进行了回顾性分析。
64 例宫颈癌患者接受了剖腹根治性腹部子宫颈切除术。由于术中发现不理想,有 2 例患者需要立即行根治性子宫切除术。中位年龄为 29.5 岁(范围,11-41 岁)。组织学包括 8 例(12.9%)腺癌,50 例(80.65%)鳞状细胞癌,1 例(1.61%)腺鳞癌和 3 例(4.84%)葡萄状肉瘤。评估的淋巴结中位数为 25 个(范围,12-53 个);10 例(16.13%)有病理危险因素的患者接受了辅助治疗。36 例 IB1 病例中有 14 例肿瘤直径大于 2cm。中位随访 22.8 个月无复发。5 例(8.06%)患者发生术后宫颈狭窄,均发生在我们开始在手术中常规安装 T 型宫内节育器之前。38 例患者完成了旨在了解哪些因素影响这些患者生殖结局的调查。由于各种原因,只有 10 例患者尝试怀孕,其中 2 例成功。其中 1 例经剖宫产分娩 39 周,另 1 例目前怀孕。
对于肿瘤直径不超过 4cm 的经验丰富的妇科肿瘤学家进行保留生育功能的根治性腹部子宫颈切除术似乎是一种合理的选择。主要的围手术期并发症是术后宫颈狭窄,通过在手术中安装带尾的 T 型宫内节育器可以有效预防。社会、家庭和身体因素在很大程度上影响了患者的生殖结局。生殖问题和生活质量问题需要进一步调查。